AstraZeneca and Merck report Lynparza's significant survival benefits in high-risk breast cancer and Keytruda combo results ...

The AstraZeneca share price is down almost 20% since September! What’s behind this drop, and where do analysts think the ...

AstraZeneca (AZN) and Merck (MRK) reported positive long-term survival data for their drug Lynparza in the treatment of ...

In a report released today, Steve Scala from TD Cowen maintained a Buy rating on AstraZeneca (AZN – Research Report), with a price target of ...

Shares of AstraZeneca PLC AZN inched up 0.45% to £107.02 Monday, on what proved to be an all-around favorable trading session ...

With AstraZeneca’s former international chief, Leon Wang, under investigation in China, the company has promoted an AZ ...

Shares of AstraZeneca PLC AZN slid 1.78% to £105.12 Tuesday, on what proved to be an all-around dismal trading session for ...

Trying to break from the decade-old practice of using BTK inhibitors indefinitely to treat blood cancer, AstraZeneca has ...

The breast cancer drug Enhertu will be added to China’s national health insurance scheme beginning in the new year — despite ...

British drugmaker AstraZeneca has appointed a new China head, replacing a former executive who has been detained by ...

NEW YORK, NY / ACCESSWIRE / December 11, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of AstraZeneca PLC ...

AstraZeneca appoints Iskra Reic as executive vice president, international: Cambridge, UK Friday, December 6, 2024, 13:30 Hrs ...